Small-molecule Complement Inhibitors

Small-Molecule Complement Inhibitor is a pharmacological agent that belongs to the class of complement-targeted therapies and is distinguished by its low molecular weight, enabling oral bioavailability and specific modulation of complement system proteins to inhibit pathological immune activation.

92

Publications

5.3K

Citations

743

Authors

255

Institutions

Publications per year

2017–2026

27

Authors

743

  1. JD
    John D. Lambris

    University of Pennsylvania, United States

    8 publications · 531 citations

    8

    h-index

  2. DR
    Daniel Ricklin

    University of Pennsylvania, United States

    7 publications · 506 citations

    7

    h-index

  3. AM
    Antonio M. Risitano

    University of Naples Federico II, Italy

    6 publications · 901 citations

    6

    h-index

  4. KA
    Karen Anderson

    University of California San Diego, United States

    6 publications · 425 citations

    6

    h-index

  5. FC
    Frédéric Cumin

    Novartis (Switzerland), Switzerland

    5 publications · 404 citations

    5

    h-index

1–5 of 743

Venues

  1. Blood

    10 publications · 570 citations

    10

    h-index

  2. Bioorganic & Medicinal Chemistry Letters

    9 publications · 183 citations

    9

    h-index

  3. Journal of Medicinal Chemistry

    7 publications · 558 citations

    7

    h-index

  4. Molecular Immunology

    6 publications · 139 citations

    6

    h-index

  5. The Journal of Immunology

    JI · 5 publications · 153 citations

    5

    h-index

1–5